http://www.hhmi.org/bulletin/dec2001/gleevec/Howard Hughes Medical Institute article, available in HTML and PDF format.Gleevec seemed to spring up overnight. "Powerful Anti-Cancer Drug Emerges from Basic Biology," trumpeted The New York Times on May 8. Two days later, the Food and Drug Administration (FDA) announced its approval after a record-breaking review period of only two and a half months. With words such as
waiting for hand_moderationHHMIBulletinGleevecsGloryDaysDrugs and Medications > I > Imatinib
Manufacturer's information on this prescription medication used in the treatment of Chronic Myelogenous Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST).